Searched over 200M research papers for "chemotherapy pills"
10 papers analyzed
These studies suggest that combining chemotherapy pills with various adjunct therapies, such as Xihuang pill, Shexiang Baoxin Pill, Ginsenoside H dripping pills, and COX-2 inhibitors, can enhance therapeutic effects, improve quality of life, and reduce side effects in cancer patients.
20 papers analyzed
Chemotherapy pills are a cornerstone in the treatment of various cancers, offering a non-invasive alternative to intravenous chemotherapy. However, their use is often accompanied by significant side effects and challenges such as drug resistance and reduced quality of life for patients. Recent research has explored the combination of chemotherapy pills with traditional Chinese medicine (TCM) to enhance therapeutic efficacy and mitigate adverse effects.
Studies have shown that combining Xihuang pill with standard chemotherapy regimens, such as FOLFOX or FOLFIRI, significantly improves therapeutic outcomes in patients with advanced colorectal cancer. The response rate in patients receiving the combined treatment was notably higher compared to those receiving chemotherapy alone. A meta-analysis further supports these findings, indicating that Xihuang pill enhances tumor response and disease control, prolongs overall survival, and improves the quality of life for cancer patients.
The combination of Xihuang pill with chemotherapy not only boosts efficacy but also reduces the side effects associated with chemotherapy. Patients treated with this combination experienced fewer instances of leukocyte and platelet count reduction, which are common side effects of chemotherapy. Additionally, in breast cancer patients, Xihuang pill significantly reduced adverse events such as nausea, vomiting, and hepatic function damage.
Shexiang Baoxin Pill (SBP), traditionally used for cardiovascular diseases, has shown promise in enhancing the delivery and efficacy of chemotherapeutic agents like gemcitabine. SBP increases tumor angiogenesis and blood perfusion, facilitating better drug delivery to tumor sites and overcoming multidrug resistance. This combination therapy not only improves treatment efficiency but also minimizes the toxic side effects of chemotherapy.
Ginsenoside H dripping pills, when combined with cyclophosphamide, have demonstrated a synergistic effect in inhibiting tumor recurrence and improving the quality of life in postoperative non-small-cell lung cancer (NSCLC) patients. This combination alleviates symptoms such as splenomegaly and emaciation, which are common in cancer patients undergoing chemotherapy.
The spleen-invigorating pill (SIP) has shown protective effects against the cytotoxicity induced by 5-fluorouracil (5-FU) in bone marrow stromal cells. SIP enhances cell survival, reduces apoptosis, and modulates oxidative stress-related proteins, thereby mitigating the damage caused by chemotherapy. This suggests that SIP could be a valuable adjuvant in chemotherapy to protect healthy cells and improve patient outcomes.
The integration of traditional Chinese medicine, such as Xihuang pill, Shexiang Baoxin pill, Ginsenoside H dripping pills, and spleen-invigorating pill, with conventional chemotherapy regimens offers a promising approach to enhance therapeutic efficacy and reduce side effects. These combinations not only improve tumor response and patient survival but also alleviate the adverse effects of chemotherapy, thereby improving the overall quality of life for cancer patients. Further high-quality clinical trials are needed to validate these findings and optimize treatment protocols.
Most relevant research papers on this topic